 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper   
127th MAINE LEGISLATURE  
 
SECOND REGULAR SESSION -2016  
 
Legislative Document  No. 1552  
H.P. 1057  House of Representatives, January 12, 2016  
 
 
An Act To Reduce Morbidity and Mortality Related to Injected 
Drugs  
 
(AFTER DEADLINE)  
 
 
 
Approved for introduction by a majority of the Legislative Council pursuant to Joint Rule 
205. 
Reference to the Committee on Health and Human Services suggested and ordered printed.  
 
 
  
 ROBERT B. HUNT  
 Clerk  
 
Presented by Representative VACHON of Scarborough.  
Cosponsored by Senator HASKELL of Cumberland and  
Representatives: DUNPHY of Embden, GATTINE of Westbrook, HEAD of Bethel, 
MALABY of Hancock, REED of Carmel, SANBORN of Gorham, TURNER of Burlington, 
WARD of Dedham.  
 
 

 
 Page 1 - 127LR2590(01) -1 
 Be it enacted by the People of the State of Maine as follows:  1 
Sec. 1.  22 MRSA ยง1341, sub -ยง4 is enacted to read:  2 
4.  Funding.  This subsection governs funding for hypodermic apparatus exchange 3 
programs certified pursuant to this section.  4 
A.  The Maine Cent er for Disease Control and Prevention shall allocate any funds 5 
appropriated for hypodermic apparatus exchange programs among programs based on 6 
rates of intravenous drug use and negative health outcomes related to drug use in the 7 
geographic area surrounding  a program and the amount of services historically 8 
provided by the program, except that the center may award funds through a 9 
competitive grant process in order to facilitate the operation of programs in counties 10 
without programs.  11 
B.  Unless the use of fund s to support a hypodermic apparatus exchange program is 12 
prohibited by the original funding source, the department may not prohibit funds it 13 
awards to an entity involved in HIV, viral hepatitis and substance abuse issues from 14 
being used to support a hypoder mic apparatus exchange program as long as the 15 
services the program provides can reasonably be expected to contribute to the desired 16 
result identified when the funding is first made available.  17 
Sec. 2.  Appropriations and allocations.  The following appropri ations and 18 
allocations are made.  19 
HEALTH AND HUMAN SERVICES, DEPARTMENT OF (FORMERLY DHS)  20 
Maine Center for Disease Control and Prevention 0143  21 
Initiative:  Appropriates funds for existing hypodermic apparatus exchange programs 22 
certified by the Maine Center for Disease Control and Prevention.  23 
 24 
 25 
 26 
 27 
 28 
 
Maine Center for Disease Control and Prevention 0143  29 
Initiative:  Appropriates funds to facilitate the growth of new hypoderm ic apparatus 30 
exchange programs certified by the Maine Center for Disease Control and Prevention in 31 
counties without a program.  32 
 33 
 34 
 35 
 36 
 37 
 
 38 GENERAL FUND  2015 -16 2016 -17 
All Other  $0 $50,000  
 
  
  
GENERAL FUND TOTAL  $0 $50,000  
GENERAL FUND  2015 -16 2016 -17 
All Other  $0 $25,000  
 
  
  
GENERAL FUND TOTAL  $0 $25,000  
 
 Page 2 - 127LR2590(01) -1 
  1 
 2 
 3 
 4 
 5 
 6 
 7 
 
SUMMARY  8 
This bill provides funding for existing and new hypodermic apparatus exchange 9 
programs certified by the De partment of Health and Human Services, Maine Center for 10 
Disease Control and Prevention.  The center must allocate funds appropriated for existing 11 
hypodermic apparatus exchange programs among programs based on rates of intravenous 12 
drug use and negative heal th outcomes related to drug use in the geographic area 13 
surrounding a program and the amount of services historically provided by the program, 14 
except that funds awarded in order to facilitate the operation of programs in counties 15 
without a program may be aw arded through a competitive grant process.  It also provides 16 
that, unless the use of funds to support a hypodermic apparatus exchange program is 17 
prohibited by the original funding source, the department may not prohibit funds it 18 
awards to an entity involve d in HIV, viral hepatitis and substance abuse issues from being 19 
used to support a hypodermic apparatus exchange program as long as the services the 20 
program provides can reasonably be expected to contribute to the desired result identified 21 
when the funding is first made available.  22 
 HEALTH AND HUMAN SERVICES, 
DEPART MENT OF (FORMERLY DHS) 
DEPARTMENT TOTALS  2015 -16 2016 -17 
   
GENERAL FUND  $0 $75,000  
 
  
  
DEPARTMENT TOTAL - ALL FUNDS  $0 $75,000  
